Check-Cap(CHEK) - 2023 Q2 - Quarterly Report

Exhibit 99.1 Check-Cap Reports First Quarter 2023 Financial Results ISFIYA, Israel, May 11, 2023 -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free screening test to detect polyps before they may transform into colorectal cancer (CRC), today announced financial results for the first quarter ended March 31, 2023. Recent Highlights: • In March 2023, the Company ...